GJ103 sodium salt

CAS No. 1459687-96-7

GJ103 sodium salt( GJ 103 sodium salt | GJ-103 sodium salt )

Catalog No. M11982 CAS No. 1459687-96-7

A novel small molecular read-through (SMRT) compound that can induce read through of nonsense mutations in the ATM gene.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 In Stock
5MG 70 In Stock
10MG 113 In Stock
25MG 230 In Stock
50MG 398 In Stock
100MG 433 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GJ103 sodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel small molecular read-through (SMRT) compound that can induce read through of nonsense mutations in the ATM gene.
  • Description
    A novel small molecular read-through (SMRT) compound that can induce read through of nonsense mutations in the ATM gene; induces ATM kinase on both TGA and TAG stop codons and restores ATMpSer1981 autophosphorylation and SMC1pSer966 transphosphorylation in A-T cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GJ 103 sodium salt | GJ-103 sodium salt
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ATM/ATR
  • Recptor
    ATM
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    1459687-96-7
  • Formula Weight
    364.35418928
  • Molecular Formula
    C16H13N4NaO3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 34 mg/mL
  • SMILES
    COC1=CC=CC(=C1)N2C(=NN=C2SCC(=O)[O-])C3=CC=CC=N3.[Na+]
  • Chemical Name
    Acetic acid, 2-[[4-(3-methoxyphenyl)-5-(2-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-, sodium salt (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Du L, et al. Mol Ther. 2013 Sep;21(9):1653-60.
molnova catalog
related products
  • VE822

    VE-822 is an ATR inhibitor with IC50 of 19 nM in HT29 cells.

  • Ro 90-7501

    Ro 90-7501 is an amyloid β42 (Aβ42) protofibrillar and TPR-dependent PP5 inhibitor, a novel radiosensitizer for cervical cancer cells, which inhibits ATM phosphorylation, promotes apoptosis, and induces cell-cycle arrest.

  • AZD1390

    AZD1390 (AZD-1390) is a novel potent, selective, orally available and CNS penetrant ATM inhibitor with IC50 of 0.78 nM.Brain Cancer,Phase 1 Clinical